{"id":355,"date":"2020-04-17T02:46:52","date_gmt":"2020-04-17T02:46:52","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=355"},"modified":"2023-08-29T17:44:52","modified_gmt":"2023-08-29T17:44:52","slug":"mgc-pharma-micelle-technology-clinical-trial-anti-infective-drug-covid-19-patients","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=355","title":{"rendered":"MGC Pharma\u5236\u836f\u516c\u53f8\u548cMicelle Technology\u5f00\u59cb\u5728COVID-19\u60a3\u8005\u8eab\u4e0a\u4f7f\u7528\u6297\u611f\u67d3\u836f\u7269\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c"},"content":{"rendered":"<p>MGC Pharmaceuticals (ASX: MXC)\u5373\u5c06\u542f\u52a8\u4e00\u9879\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u4e00\u79cd\u5929\u7136\u6297\u611f\u67d3\u836f\u7269\u5bf9COVID19\u60a3\u8005\u7684\u7597\u6548\u3002<\/p>\n<p>\u4ee5\u8272\u5217Nazareth\u533b\u9662\u4eba\u4f53\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a\u5df2\u6279\u51c6MGC\u8fdb\u884c\u4e00\u9879\u8bd5\u9a8c\uff0c\u4ee5\u8bc4\u4f30\u8fd9\u79cd\u5929\u7136ArtemiC\u836f\u7269\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002\u8fd9\u79cd\u836f\u7269\u7684\u8bbe\u8ba1\u76ee\u6807\u662f\u6709\u708e\u75c7\u5e76\u53d1\u75c7\u7684\u75c5\u6bd2\u611f\u67d3\u3002<\/p>\n<p>\u672c\u5468\u65e9\u4e9b\u65f6\u5019\uff0c\u745e\u58ebPhamaCan\u7684\u6bcd\u516c\u53f8Micelle Technology\u5ba3\u5e03\u4e86\u4e00\u9879\u5177\u6709\u7ea6\u675f\u529b\u7684\u534f\u8bae\u3002<\/p>\n<p>Micelle\u7684\u9886\u5148\u6280\u672f\u4e4b\u4e00\u662f\u5176MyCell\u4f20\u9012\u79d1\u6280\uff0c\u8be5\u7cfb\u7edf\u65e8\u5728\u6539\u5584\u5929\u7136\u6d3b\u6027\u6210\u5206(\u5982ArtemiC\u4e2d\u7684\u6d3b\u6027\u6210\u5206)\u7684\u836f\u4ee3\u52a8\u529b\u5b66\u3002<\/p>\n<p>\u4e3a\u4e86\u521b\u9020ArtemiC \uff0cMicelle\u4f7f\u7528\u4e86MyCell\u4f20\u9012\u79d1\u6280\u5c06artemisinin\u3001curcumin\u3001\u7ef4\u751f\u7d20C\u548cboswellia serrata\u76f8\u7ed3\u5408\u2014\u2014\u8fd9\u4e9b\u90fd\u4ee5\u5177\u6709\u5929\u7136\u6297\u611f\u67d3\u7279\u6027\u800c\u95fb\u540d\u3002<\/p>\n<p>\u5728\u6700\u8fd1\u4f7f\u7528\u8be5\u836f\u7269\u7684\u8bd5\u9a8c\u4e2d\uff0cMicelle\u5df2\u7ecf\u6210\u529f\u5730\u7528\u4e8e\u6cbb\u7597\u4f20\u67d3\u75c5\u548c\u5305\u62ec\u759f\u75be\u5728\u5185\u7684\u6025\u6027\u75be\u75c5\u3002<\/p>\n<h2>\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c<\/h2>\n<p>\u6839\u636e\u534f\u8bae\uff0cMGC\u5c06\u4e3aMicelle\u63d0\u4f9b\u5fc5\u8981\u7684\u7814\u7a76\u652f\u6301\uff0c\u4ee5\u5f00\u53d1\u6700\u7ec8\u7684ArtemiC\u4ea7\u54c1\u3002<\/p>\n<p>\u201c\u5728\u6211\u4eec\u6700\u8fd1\u5ba3\u5e03\u4e0eMicelle\u8fbe\u6210\u534f\u8bae\u540e\uff0c\u7acb\u5373\u6279\u51c6\u8fdb\u884cArtemiC\u836f\u7269\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u662f\u4e00\u4e2a\u91cd\u8981\u7684\u91cc\u7a0b\u7891\uff0c\u201dMGC\u8054\u5408\u521b\u59cb\u4eba\u517c\u8463\u4e8b\u603b\u7ecf\u7406Roby Zomer\u8bf4\u3002<\/p>\n<p>\u4ed6\u8865\u5145\u8bf4:\u201c\u8fd9\u9879\u8bd5\u9a8c\u5c06\u8bc4\u4f30ArtmiC\u5bf9COVID-19\u60a3\u8005\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\uff0c\u6211\u4eec\u671f\u5f85\u7740\u5e02\u573a\u7684\u53d1\u5c55\u3002\u201d<\/p>\n<p>MGC\u8ba1\u5212\u672c\u6708\u5f00\u59cb\u8bd5\u9a8c\uff0c\u5c06\u5305\u62ec50\u540dCOVID-19\u540d\u60a3\u8005\uff0c\u6bcf\u4e2a\u60a3\u8005\u63a5\u53d714\u5929\u7684\u6cbb\u7597\u3002<\/p>\n<p>\u9884\u8ba1\u8bd5\u9a8c\u5c06\u4e8e9\u6708\u7ed3\u675f\uff0c\u7ed3\u679c\u5c06\u4e8e10\u6708\u516c\u5e03\u3002<\/p>\n<p>\u5982\u679c\u8bd5\u9a8c\u6210\u529f\uff0cMGC\u548cMicelle\u5c06\u8bc4\u4f30\u662f\u5426\u9700\u8981\u989d\u5916\u7684\u4e34\u5e8a\u9879\u76ee\u3002<\/p>\n<p>\u7136\u540e\uff0c\u5982\u679c\u8fbe\u5230\u5546\u4e1a\u5316\u9636\u6bb5\uff0cMGC\u5c06\u8d1f\u8d23\u5728\u65af\u6d1b\u6587\u5c3c\u4e9a\u7684\u7b26\u5408\u6b27\u76df\u6807\u51c6\u7684\u5de5\u5382\u751f\u4ea7\u548c\u5305\u88c5\u8ba2\u5355\u3002<\/p>\n<p>\u5e02\u573a\u5bf9MGC\u7684\u6d88\u606f\u53cd\u5e94\u79ef\u6781\uff0c\u63a8\u52a8\u5176\u80a1\u4ef7\u4e0a\u6da836%\uff0c\u622a\u81f3\u5348\u76d8\u62a50.034\u6fb3\u5143\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>MGC Pharmaceuticals (ASX: MXC)\u5373\u5c06\u542f\u52a8\u4e00\u9879\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u4e00\u79cd\u5929\u7136\u6297\u611f\u67d3\u836f\u7269\u5bf9COVID19\u60a3\u8005\u7684\u7597\u6548\u3002 \u4ee5\u8272\u5217Nazareth\u533b\u9662\u4eba\u4f53\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a\u5df2\u6279\u51c6MGC\u8fdb\u884c\u4e00\u9879\u8bd5\u9a8c\uff0c\u4ee5\u8bc4\u4f30\u8fd9\u79cd\u5929\u7136ArtemiC\u836f\u7269\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002\u8fd9\u79cd\u836f\u7269\u7684\u8bbe\u8ba1\u76ee\u6807\u662f\u6709\u708e\u75c7\u5e76\u53d1\u75c7\u7684\u75c5\u6bd2\u611f\u67d3\u3002 \u672c\u5468\u65e9\u4e9b\u65f6\u5019\uff0c\u745e\u58ebPhamaCan\u7684\u6bcd\u516c\u53f8Micelle Technology\u5ba3\u5e03\u4e86\u4e00\u9879\u5177\u6709\u7ea6\u675f\u529b\u7684\u534f\u8bae\u3002 Micelle\u7684\u9886\u5148\u6280\u672f\u4e4b\u4e00\u662f\u5176MyCell\u4f20\u9012\u79d1\u6280\uff0c\u8be5\u7cfb\u7edf\u65e8\u5728\u6539\u5584\u5929\u7136\u6d3b\u6027\u6210\u5206(\u5982ArtemiC\u4e2d\u7684\u6d3b\u6027\u6210\u5206)\u7684\u836f\u4ee3\u52a8\u529b\u5b66\u3002 \u4e3a\u4e86\u521b\u9020ArtemiC \uff0cMicelle\u4f7f\u7528\u4e86MyCell\u4f20\u9012\u79d1\u6280\u5c06artemisinin\u3001curcumin\u3001\u7ef4\u751f\u7d20C\u548cboswellia serrata\u76f8\u7ed3\u5408\u2014\u2014\u8fd9\u4e9b\u90fd\u4ee5\u5177\u6709\u5929\u7136\u6297\u611f\u67d3\u7279\u6027\u800c\u95fb\u540d\u3002 \u5728\u6700\u8fd1\u4f7f\u7528\u8be5\u836f\u7269\u7684\u8bd5\u9a8c\u4e2d\uff0cMicelle\u5df2\u7ecf\u6210\u529f\u5730\u7528\u4e8e\u6cbb\u7597\u4f20\u67d3\u75c5\u548c\u5305\u62ec\u759f\u75be\u5728\u5185\u7684\u6025\u6027\u75be\u75c5\u3002 \u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c \u6839\u636e\u534f\u8bae\uff0cMGC\u5c06\u4e3aMicelle\u63d0\u4f9b\u5fc5\u8981\u7684\u7814\u7a76\u652f\u6301\uff0c\u4ee5\u5f00\u53d1\u6700\u7ec8\u7684ArtemiC\u4ea7\u54c1\u3002 \u201c\u5728\u6211\u4eec\u6700\u8fd1\u5ba3\u5e03\u4e0eMicelle\u8fbe\u6210\u534f\u8bae\u540e\uff0c\u7acb\u5373\u6279\u51c6\u8fdb\u884cArtemiC\u836f\u7269\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u662f\u4e00\u4e2a\u91cd\u8981\u7684\u91cc\u7a0b\u7891\uff0c\u201dMGC\u8054\u5408\u521b\u59cb\u4eba\u517c\u8463\u4e8b\u603b\u7ecf\u7406Roby Zomer\u8bf4\u3002 \u4ed6\u8865\u5145\u8bf4:\u201c\u8fd9\u9879\u8bd5\u9a8c\u5c06\u8bc4\u4f30ArtmiC\u5bf9COVID-19\u60a3\u8005\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\uff0c\u6211\u4eec\u671f\u5f85\u7740\u5e02\u573a\u7684\u53d1\u5c55\u3002\u201d MGC\u8ba1\u5212\u672c\u6708\u5f00\u59cb\u8bd5\u9a8c\uff0c\u5c06\u5305\u62ec50\u540dCOVID-19\u540d\u60a3\u8005\uff0c\u6bcf\u4e2a\u60a3\u8005\u63a5\u53d714\u5929\u7684\u6cbb\u7597\u3002 \u9884\u8ba1\u8bd5\u9a8c\u5c06\u4e8e9\u6708\u7ed3\u675f\uff0c\u7ed3\u679c\u5c06\u4e8e10\u6708\u516c\u5e03\u3002 \u5982\u679c\u8bd5\u9a8c\u6210\u529f\uff0cMGC\u548cMicelle\u5c06\u8bc4\u4f30\u662f\u5426\u9700\u8981\u989d\u5916\u7684\u4e34\u5e8a\u9879\u76ee\u3002 \u7136\u540e\uff0c\u5982\u679c\u8fbe\u5230\u5546\u4e1a\u5316\u9636\u6bb5\uff0cMGC\u5c06\u8d1f\u8d23\u5728\u65af\u6d1b\u6587\u5c3c\u4e9a\u7684\u7b26\u5408\u6b27\u76df\u6807\u51c6\u7684\u5de5\u5382\u751f\u4ea7\u548c\u5305\u88c5\u8ba2\u5355\u3002 \u5e02\u573a\u5bf9MGC\u7684\u6d88\u606f\u53cd\u5e94\u79ef\u6781\uff0c\u63a8\u52a8\u5176\u80a1\u4ef7\u4e0a\u6da836%\uff0c\u622a\u81f3\u5348\u76d8\u62a50.034\u6fb3\u5143\u3002<\/p>\n","protected":false},"author":3,"featured_media":356,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[136],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>MGC Pharma\u5236\u836f\u516c\u53f8\u548cMicelle Technology\u5f00\u59cb\u5728COVID-19\u60a3\u8005\u8eab\u4e0a\u4f7f\u7528\u6297\u611f\u67d3\u836f\u7269\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c<\/title>\n<meta name=\"description\" content=\"MGC Pharmaceuticals (ASX: MXC)\u5373\u5c06\u542f\u52a8\u4e00\u9879\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u4e00\u79cd\u5929\u7136\u6297\u611f\u67d3\u836f\u7269\u5bf9COVID19\u60a3\u8005\u7684\u7597\u6548\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MGC Pharma\u5236\u836f\u516c\u53f8\u548cMicelle Technology\u5f00\u59cb\u5728COVID-19\u60a3\u8005\u8eab\u4e0a\u4f7f\u7528\u6297\u611f\u67d3\u836f\u7269\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c\" \/>\n<meta property=\"og:description\" content=\"MGC Pharmaceuticals (ASX: MXC)\u5373\u5c06\u542f\u52a8\u4e00\u9879\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u4e00\u79cd\u5929\u7136\u6297\u611f\u67d3\u836f\u7269\u5bf9COVID19\u60a3\u8005\u7684\u7597\u6548\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/mgc-pharma-micelle-technology-clinical-trial-anti-infective-drug-covid-19-patients\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2020-04-17T02:46:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:44:52+00:00\" \/>\n<meta name=\"author\" content=\"Lorna Nicholas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"MGC Pharma\u5236\u836f\u516c\u53f8\u548cMicelle Technology\u5f00\u59cb\u5728COVID-19\u60a3\u8005\u8eab\u4e0a\u4f7f\u7528\u6297\u611f\u67d3\u836f\u7269\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c\" \/>\n<meta name=\"twitter:description\" content=\"MGC Pharmaceuticals (ASX: MXC)\u5373\u5c06\u542f\u52a8\u4e00\u9879\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u4e00\u79cd\u5929\u7136\u6297\u611f\u67d3\u836f\u7269\u5bf9COVID19\u60a3\u8005\u7684\u7597\u6548\u3002\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/04\/MGC-Pharma-Micelle-Technology-clinical-trial-anti-infective-drug-COVID-19-patients-ASX-MXC.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lorna Nicholas\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/mgc-pharma-micelle-technology-clinical-trial-anti-infective-drug-covid-19-patients\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/mgc-pharma-micelle-technology-clinical-trial-anti-infective-drug-covid-19-patients\/\",\"name\":\"MGC Pharma\u5236\u836f\u516c\u53f8\u548cMicelle Technology\u5f00\u59cb\u5728COVID-19\u60a3\u8005\u8eab\u4e0a\u4f7f\u7528\u6297\u611f\u67d3\u836f\u7269\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2020-04-17T02:46:52+00:00\",\"dateModified\":\"2023-08-29T17:44:52+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\"},\"description\":\"MGC Pharmaceuticals (ASX: MXC)\u5373\u5c06\u542f\u52a8\u4e00\u9879\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u4e00\u79cd\u5929\u7136\u6297\u611f\u67d3\u836f\u7269\u5bf9COVID19\u60a3\u8005\u7684\u7597\u6548\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/mgc-pharma-micelle-technology-clinical-trial-anti-infective-drug-covid-19-patients\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/mgc-pharma-micelle-technology-clinical-trial-anti-infective-drug-covid-19-patients\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/mgc-pharma-micelle-technology-clinical-trial-anti-infective-drug-covid-19-patients\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MGC Pharma\u5236\u836f\u516c\u53f8\u548cMicelle Technology\u5f00\u59cb\u5728COVID-19\u60a3\u8005\u8eab\u4e0a\u4f7f\u7528\u6297\u611f\u67d3\u836f\u7269\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\",\"name\":\"Lorna Nicholas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"caption\":\"Lorna Nicholas\"},\"description\":\"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=3\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"MGC Pharma\u5236\u836f\u516c\u53f8\u548cMicelle Technology\u5f00\u59cb\u5728COVID-19\u60a3\u8005\u8eab\u4e0a\u4f7f\u7528\u6297\u611f\u67d3\u836f\u7269\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c","description":"MGC Pharmaceuticals (ASX: MXC)\u5373\u5c06\u542f\u52a8\u4e00\u9879\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u4e00\u79cd\u5929\u7136\u6297\u611f\u67d3\u836f\u7269\u5bf9COVID19\u60a3\u8005\u7684\u7597\u6548\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"MGC Pharma\u5236\u836f\u516c\u53f8\u548cMicelle Technology\u5f00\u59cb\u5728COVID-19\u60a3\u8005\u8eab\u4e0a\u4f7f\u7528\u6297\u611f\u67d3\u836f\u7269\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c","og_description":"MGC Pharmaceuticals (ASX: MXC)\u5373\u5c06\u542f\u52a8\u4e00\u9879\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u4e00\u79cd\u5929\u7136\u6297\u611f\u67d3\u836f\u7269\u5bf9COVID19\u60a3\u8005\u7684\u7597\u6548\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/mgc-pharma-micelle-technology-clinical-trial-anti-infective-drug-covid-19-patients\/","og_site_name":"smallcapsCN","article_published_time":"2020-04-17T02:46:52+00:00","article_modified_time":"2023-08-29T17:44:52+00:00","author":"Lorna Nicholas","twitter_card":"summary_large_image","twitter_title":"MGC Pharma\u5236\u836f\u516c\u53f8\u548cMicelle Technology\u5f00\u59cb\u5728COVID-19\u60a3\u8005\u8eab\u4e0a\u4f7f\u7528\u6297\u611f\u67d3\u836f\u7269\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c","twitter_description":"MGC Pharmaceuticals (ASX: MXC)\u5373\u5c06\u542f\u52a8\u4e00\u9879\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u4e00\u79cd\u5929\u7136\u6297\u611f\u67d3\u836f\u7269\u5bf9COVID19\u60a3\u8005\u7684\u7597\u6548\u3002","twitter_image":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/04\/MGC-Pharma-Micelle-Technology-clinical-trial-anti-infective-drug-COVID-19-patients-ASX-MXC.jpg","twitter_misc":{"Written by":"Lorna Nicholas"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/mgc-pharma-micelle-technology-clinical-trial-anti-infective-drug-covid-19-patients\/","url":"https:\/\/smallcapscn.x5view.co\/mgc-pharma-micelle-technology-clinical-trial-anti-infective-drug-covid-19-patients\/","name":"MGC Pharma\u5236\u836f\u516c\u53f8\u548cMicelle Technology\u5f00\u59cb\u5728COVID-19\u60a3\u8005\u8eab\u4e0a\u4f7f\u7528\u6297\u611f\u67d3\u836f\u7269\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2020-04-17T02:46:52+00:00","dateModified":"2023-08-29T17:44:52+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60"},"description":"MGC Pharmaceuticals (ASX: MXC)\u5373\u5c06\u542f\u52a8\u4e00\u9879\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u4e00\u79cd\u5929\u7136\u6297\u611f\u67d3\u836f\u7269\u5bf9COVID19\u60a3\u8005\u7684\u7597\u6548\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/mgc-pharma-micelle-technology-clinical-trial-anti-infective-drug-covid-19-patients\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/mgc-pharma-micelle-technology-clinical-trial-anti-infective-drug-covid-19-patients\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/mgc-pharma-micelle-technology-clinical-trial-anti-infective-drug-covid-19-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"MGC Pharma\u5236\u836f\u516c\u53f8\u548cMicelle Technology\u5f00\u59cb\u5728COVID-19\u60a3\u8005\u8eab\u4e0a\u4f7f\u7528\u6297\u611f\u67d3\u836f\u7269\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60","name":"Lorna Nicholas","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","caption":"Lorna Nicholas"},"description":"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.","url":"https:\/\/smallcapscn.x5view.co\/?author=3"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/355"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=355"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/355\/revisions"}],"predecessor-version":[{"id":7498,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/355\/revisions\/7498"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/356"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=355"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=355"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=355"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}